Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 8Polycystic Ovary Syndrome 5Multiple Myeloma 5Prostatic Neoplasms 4Neoplasm Metastasis 3Colorectal Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thrombosis 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Rectal Neoplasms 1Perioperative Inflammatory Response 1Ovarian Neoplasms 1Osteosarcoma 1Neurotoxicity Syndromes 1

Interventions

Radiotherapy 4Paclitaxel 4Carboplatin 4Sodium Chloride 3Oxaliplatin 3Cyclophosphamide 3Vincristine 2Surveys and Questionnaires 2Procarbazine 2Prednisolone 2Methotrexate 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Magnesium Sulfate 2Leucovorin 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Gluconate 2Amifostine 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurotoxicity Syndromes × Simvastatin × Clear all
NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Active not recruiting
37 enrolled
Lymphoid

Lymphoma, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡